JI
Congress trade
Sen. James Inhofe (R-OK) bought $15K-$50K of Celgene Corporation (CELG) stock
James Inhofe, U.S. Senator (R-OK), disclosed a purchase of Celgene Corporation (CELG) stock worth $15K-$50K in a STOCK Act filing on Jul 25, 2018.
The trade happened on Jul 12, 2018, 13 days before it was made public.
- Traded
- Jul 12, 2018
- Disclosed
- Jul 25, 2018
- Filing delay
- 13 days
- Source
- STOCK Act disclosure
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.